Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bernal-Bello

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Infection|February 7, 2021
Early clinical experience with imatinib in COVID-19: Searching for a dual effectAlejandro Morales-Ortega, Luis Rivas-Prado, Begoña Frutos-Pérez, et al.
Viruses|October 27, 2022
Comparative Study of Vaccinated and Unvaccinated Hospitalised Patients: A Retrospective Population Study of 500 Hospitalised Patients with SARS-CoV-2 Infection in a Spanish Population of 220,000 InhabitantsJosé M Ruiz-Giardin, Marta Rivilla, Nieves Mesa, et al.
Autoimmunity Reviews|April 10, 2024
Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosisMayka Freire, Bernardo Sopeña, Arturo González-Quintela, et al.
Viruses|September 28, 2023
Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated FactorsJuan Víctor San Martín-López, Nieves Mesa, David Bernal-Bello, et al.
Autoimmunity Reviews|March 26, 2021
Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507]Manuel Rubio-Rivas, Xavier Corbella, Alfredo Guillén-Del-Castillo, et al.
The Lancet. Respiratory Medicine|May 16, 2025
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trialsAlain Amstutz, Stefan Schandelmaier, Hannah Ewald, et al.
Journal of Medical Virology|January 14, 2023
Baricitinib or imatinib in hospitalized COVID-19 patients: Results from COVINIB, an exploratory randomized clinical trialAlejandro Morales-Ortega, Ana Isabel Farfán-Sedano, Juan Víctor San Martín-López, et al.
Autoimmunity Reviews|March 21, 2020
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validationManuel Rubio-Rivas, Xavier Corbella, Alfredo Guillén-Del-Castillo, et al.
Journal of Medical Virology|November 30, 2021
Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patientsMiguel A Duarte-Millán, Nieves Mesa-Plaza, Marta Guerrero-Santillán, et al.
Journal of Medical Internet Research|July 10, 2025
AI Predictive Model of Mortality and Intensive Care Unit Admission in the COVID-19 Pandemic: Retrospective Population Cohort Study of 12,000 PatientsJose Manuel Ruiz Giardin, Óscar Garnica, Nieves Mesa Plaza, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Infection|February 7, 2021
Early clinical experience with imatinib in COVID-19: Searching for a dual effectAlejandro Morales-Ortega, Luis Rivas-Prado, Begoña Frutos-Pérez, et al.
Viruses|October 27, 2022
Comparative Study of Vaccinated and Unvaccinated Hospitalised Patients: A Retrospective Population Study of 500 Hospitalised Patients with SARS-CoV-2 Infection in a Spanish Population of 220,000 InhabitantsJosé M Ruiz-Giardin, Marta Rivilla, Nieves Mesa, et al.
Autoimmunity Reviews|April 10, 2024
Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosisMayka Freire, Bernardo Sopeña, Arturo González-Quintela, et al.
Viruses|September 28, 2023
Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated FactorsJuan Víctor San Martín-López, Nieves Mesa, David Bernal-Bello, et al.
Autoimmunity Reviews|March 26, 2021
Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507]Manuel Rubio-Rivas, Xavier Corbella, Alfredo Guillén-Del-Castillo, et al.
The Lancet. Respiratory Medicine|May 16, 2025
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trialsAlain Amstutz, Stefan Schandelmaier, Hannah Ewald, et al.
Journal of Medical Virology|January 14, 2023
Baricitinib or imatinib in hospitalized COVID-19 patients: Results from COVINIB, an exploratory randomized clinical trialAlejandro Morales-Ortega, Ana Isabel Farfán-Sedano, Juan Víctor San Martín-López, et al.
Autoimmunity Reviews|March 21, 2020
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validationManuel Rubio-Rivas, Xavier Corbella, Alfredo Guillén-Del-Castillo, et al.
Journal of Medical Virology|November 30, 2021
Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patientsMiguel A Duarte-Millán, Nieves Mesa-Plaza, Marta Guerrero-Santillán, et al.
Journal of Medical Internet Research|July 10, 2025
AI Predictive Model of Mortality and Intensive Care Unit Admission in the COVID-19 Pandemic: Retrospective Population Cohort Study of 12,000 PatientsJose Manuel Ruiz Giardin, Óscar Garnica, Nieves Mesa Plaza, et al.
Pageof 4